XML 38 R24.htm IDEA: XBRL DOCUMENT
v3.25.2

Stockholder Equity (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Stockholder Equity |
Schedule of stock-based compensation expense to stock units |
|  | Three Months |  |  | Six Months Ended |
|  | June 30, 2025 |  |  | June 30, 2024 |  |  | June 30, 2025 |  |  | June 30, 2024 |
Research and development |  | $ | 64,837 |  |  | $ | 45,704 |  |  | $ | 128,640 |  |  | $ | 90,318 |
Compensation and related expenses |  |  | 484,241 |  |  |  | 229,680 |  |  |  | 1,129,902 |  |  |  | 368,266 |
Total expense |  | $ | 549,078 |  |  | $ | 275,384 |  |  | $ | 1,258,542 |  |  | $ | 458,584 |
Schedule of stock option activity |
|  |  |  |  |  |  |  |  |  |  | Weighted |
|  |  |  |  | Weighted |  |  |  |  |  | Average |
|  |  |  |  | Average |  |  | Aggregate |  |  | Remaining |
|  | Shares |  |  | Exercise Price |  |  | Intrinsic Value |  |  | Contractual Life (Years) |
Options outstanding at December 31, 2024 |  |  | 15,843,116 | * |  | $ | 0.94 |  |  | $ | 3,324,000 |  |  |  | 5.95 |
Granted |  |  | 908,659 |  |  |  | 0.66 |  |  |  | - |  |  |  | - |
Exercised |  |  | (200,000 | ) |  |  | 0.12 |  |  |  | - |  |  |  | - |
Expired/forfeit |  |  | (142,713 | ) |  |  | 2.96 |  |  |  | - |  |  |  | - |
Options outstanding at March 31, 2025 |  |  | 16,409,062 |  |  | $ | 0.92 |  |  | $ | 1,274,000 |  |  |  | 5.98 |
Granted |  |  | 1,715,152 |  |  |  | 0.29 |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Expired/forfeit |  |  | (608,712 | ) |  | $ | 0.84 |  |  |  | - |  |  |  | - |
Options outstanding at June 30, 2025 |  |  | 17,515,502 | * |  | $ | 0.86 |  |  | $ | 1,210,855 |  |  |  | 5.99 |
Options Exercisable at June 30, 2025 |  |  | 8,960,030 | * |  | $ | 0.66 |  |  | $ | 1,160,000 |  |  |  | 3.08 |
Schedule of stock option assumtion |
|  |  | June 30, |  |  |  | June 30, |
|  |  | 2025 |  |  |  | 2024 |
Expected volatility |  |  | 67.81 – 71.56% |  |  |  | 26.21 – 26.38% |
Expected term (years) |  |  | 6.25 |  |  |  | 6.25 |
Risk-free rate |  |  | 4.00 - 4.51% |  |  |  | 4.09 – 4.65% |
Dividend rate |  |  | 0.00% |  |  |  | 0.00% |
Schedule of outstanding nonvested restricted stock |
|  |  |  |  | Weighted- Average |
|  |  |  |  | Grant Date |
|  | Amount |  |  | Fair Value |
Nonvested, beginning of the year |  |  | 3,549,292 |  |  | $ | 1.23 |
Granted |  |  | 3,139,860 |  |  |  | 0.55 |
Vested |  |  | (416,333 | ) |  |  | 1.26 |
Forfeited |  |  | (60,000 | ) |  |  | 0.62 |
Nonvested, end of the year |  |  | 6,212,819 |  |  | $ | 0.89 |
Schedule of stock-based compensation expense related to stock units |
|  | Three Months |  |  | Six Months Ended |
|  | June 30, 2025 |  |  | June 30, 2024 |  |  | June 30, 2025 |  |  | June 30, 2024 |
Research and development |  | $ | 38,363 |  |  | $ | - |  |  | $ | 70,332 |  |  | $ | - |
Compensation and related expenses |  |  | 233,386 |  |  |  | 73,340 |  |  |  | 450,368 |  |  |  | 73,340 |
Total expense |  | $ | 271,749 |  |  | $ | 73,340 |  |  | $ | 520,700 |  |  | $ | 73,340 |
Schedule of warrant activity |
|  |  |  |  |  |  |  |  |  |  | Weighted |
|  |  |  |  | Weighted |  |  |  |  |  | Average |
|  |  |  |  | Average |  |  | Aggregate |  |  | Remaining |
|  |  |  |  | Exercise |  |  | Intrinsic |  |  | Contractual |
|  | Shares |  |  | Price |  |  | Value |  |  | Life (Years) |
Warrants outstanding at December 31, 2024 |  |  | 14,675,244 |  |  | $ | 1.13 |  |  | $ | - |  |  |  | 4.88 |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Expired/forfeit |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Warrants outstanding at March 31, 2025 |  |  | 14,675,244 |  |  | $ | 1.13 |  |  |  |  |  |  |  | 4.63 |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Expired/forfeit |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Warrants outstanding at June 30, 2025 |  |  | 14,675,244 |  |  | $ | 1.13 |  |  |  |  |  |  |  |  |
Warrants exercisable at June 30, 2025 |  |  | 14,675,244 |  |  | $ | 1.13 |  |  | $ | - |  |  |  | 4.39 |

X
- References No definition available. + Details
Name: | scwo_ScheduleOfStockbasedCompensationExpenseRelatedToStockUnitsTableTextBlock
Namespace Prefix: | scwo_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | scwo_ScheduleOfStockbasedCompensationExpenseToStockUnitsTableTextBlock
Namespace Prefix: | scwo_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration